MAY 20, 2020 10:15 AM PDT

Comparison of PAM50 Intrinsic Subtype Profiles in Matched Primary and Metastatic Breast Cancer Samples from the CTC-MBC Trial (NCT01322893) Shows a Significant Shift Towards More Aggressive..

  • Professor i Kirurgi, Lund University, Medical Faculty, dept of Clinical Sciences Lund, div of Oncology and Surgery

Show Resources
Show Resources